Capital Advisory Group Advisory Services’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,730
Closed -$40K 133
2022
Q3
$40K Buy
1,730
+475
+38% +$14.4K 0.03% 139
2022
Q2
$89K Buy
1,255
+155
+14% +$12.6K 0.05% 150
2022
Q1
$96K Buy
+1,100
New +$65.9K 0.04% 198

Other funds holding CELU

Capital Advisory Group Advisory Services's CELU Position: Q4 2022 in Review

Capital Advisory Group Advisory Services sold out of Celularity (CELU) in Q4 2022, closing a stake of 1,730 shares — an estimated $40K sold.

Capital Advisory Group Advisory Services first reported a position in CELU in Q1 2022 and held it in 3 quarters. The position peaked at $96K in Q1 2022. 73 funds tracked by Wall St. Rank hold CELU as of Q4 2022.

  • Capital Advisory Group Advisory Services reported no remaining Celularity position as of Q4 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 1,730 Celularity shares in Q4 2022, an estimated $40K.
  • Capital Advisory Group Advisory Services first reported a position in Celularity in Q1 2022 and held it in 3 quarters.
  • Capital Advisory Group Advisory Services's Celularity position peaked at $96K in Q1 2022.
  • 73 funds tracked by Wall St. Rank held Celularity as of Q4 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2022, filed 14 Feb 2023.